You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Claims for Patent: 6,805,686

✉ Email this page to a colleague

Summary for Patent: 6,805,686

Title:	Autoinjector with extendable needle protector shroud
Abstract:	The invention provides a syringe and a method for using the same. The syringe includes a housing having a reservoir disposed therein and a plunger to be received by the reservoir, the plunger being moveable between a first plunger position and a second plunger position. The syringe also includes a plunger spring to urge the plunger toward the second plunger position and an actuator to deploy the plunger spring. The syringe also includes a needle proximate the distal end of the housing displaceable from a first needle position to a second needle position, and a shroud coupled with the housing. The shroud is moveable between a retracted position and an extended position, the shroud surrounding at least a portion of the needle when in the extended position. The syringe also includes an interlocking assembly, a shroud spring, and a locking assembly configured to inhibit movement of the shroud.
Inventor(s):	Marwan A. Fathallah, Richard W. Grabenkort
Assignee:	AbbVie Inc
Application Number:	US10/430,710

Details for Patent 6,805,686

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	December 31, 2002	6,805,686	2023-05-06
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	February 21, 2008	6,805,686	2023-05-06
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	April 24, 2013	6,805,686	2023-05-06
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	September 23, 2014	6,805,686	2023-05-06
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	November 23, 2015	6,805,686	2023-05-06
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	March 09, 2016	6,805,686	2023-05-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,805,686

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	2004225262	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.